Gene Barnett, M.D.
| Appointed: |
1987 |
| Gender: |
Male |
| Languages: |
English |
Brain Tumor and Neuro-Oncology Center
Director, Cleveland Clinic Gamma Knife Center
Taussig Cancer Institute
Biographical Sketch
Gene H. Barnett, MD, is Director of Cleveland Clinic’s Brain Tumor and Neuro-Oncology Center; Director of the Cleveland Clinic Health System Gamma Knife Center; and Vice-Chairman of the Department of Neurological Surgery. He has served on the Board of Governors of Cleveland Clinic for a five-year term and was President of the Staff.
He has authored more than 180 articles published in leading medical journals and has a particular interest in the areas of neuro-oncology, computer-assisted surgery and stereotactic radiosurgery. In the late 1980s, Dr. Barnett created the Center for Computer-Assisted Neurosurgery at Cleveland Clinic, which established Cleveland Clinic's neurosurgery program as an innovator in following:
- Advanced stereotaxis, or the identification of discreet areas of the brain that control specific functions
- Computer applications resulting in the creation of a powerful surgical navigation system called frameless stereotaxy.
He holds several patents in these areas and continues work on the development of robotics in neurosurgery, laser lesioning systems for brain tumors and next-generation surgical navigation systems.
Dr. Barnett is the past-president of the Ohio State Neurosurgical Society, and the Northeast Ohio Neurosurgical Society. He is a state representative for the Joint Council of State Neurosurgical Societies, and he has served as Chairman of its Northwest Quadrant. He also serves on the Executive Committee of the Section on Tumors and has been on the Board of Directors of the Joint Section of Stereotactic and Functional Neurosurgery and Board of Directors of the American Association of Neurological Surgeons. In addition, he is on the editorial boards of Neurosurgery, Journal of Image Guided Surgery and Select Reviews in Neuro-Oncology. He also is a reviewer for several neurosurgery journals.
He received his degree from Case Western Reserve University School of Medicine in Cleveland, completed his residency at the Cleveland Clinic Department of Neurosurgery and his fellowship in Neurosurgery at Massachusetts General Hospital in Boston, where he was a clinical and research fellow at the Harvard Medical School and Massachusetts General Hospital.
Professional Highlights
- Rose Ella Burkhardt Chair in Brain Tumor Research
- Mahaley Clinical Brain Tumor Research Award
Education & Fellowships
| Medical School: | Case Western Reserve University School of Medicine, Cleveland, OH |
|
| Internship: | Cleveland Clinic, General Surgery, Cleveland, OH |
| Residency: | Cleveland Clinic, Neurological Surgery, Cleveland, OH |
| Fellowship: | Massachusetts General Hospital, Neurosurgical Surgery, Boston, MA |
| Other Education: | (Other) Karolinska Gamma Knife Center |
| Other Education: | (Undergraduate) Case Western Reserve University, Cleveland, OH |
Certifications
Specialty Interests
Benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, gamma knife, gamma knife and radiosurgery, Gamma Knife Radiosurgery, Meningiomas, molecular biology of brain tumors clinical and translational trials, stereotactic surgery, Trigeminal Neuralgia, tumors of the brain and spine.
Innovations & Patents
- Multiple patents in the field of surgical navigation allowing for better, safer brain tumor surgery
- Patent involving the use of a blood marker to detect presence or progression of brain tumors
Awards & Honors
- Best Doctors in America
- Top Docs
- Mahaley Clinical Brain Tumor Research Award
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Barnett has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Barnett receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Elektra Instrument, AB
- Monteris Medical Inc.
Royalty Payments. Dr. Barnett has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
Inventor Share. Dr. Barnett may receive future financial benefits from the Cleveland Clinic for inventions or discoveries related to the companies shown below:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
